Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CNMD market cap is 3.12B. The company's latest EPS is USD 2.0961 and P/E is 48.38.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 304.58M | 327.05M | 312.27M | 332.1M | 316.7M |
| Operating Income | 33.77M | 44.23M | 35.59M | 47.86M | 145.9M |
| Net Income | 15.84M | 33.07M | 19.71M | 29.98M | 48.98M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 955.1M | 862.46M | 1.01B | 1.05B | 1.24B |
| Operating Income | 79.11M | 46.01M | 109.72M | 74.74M | 122.8M |
| Net Income | 28.62M | 9.52M | 62.54M | -80.58M | 64.46M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.33B | 2.3B | 2.31B | 2.29B | 2.32B |
| Total Liabilities | 1.53B | 1.47B | 1.45B | 1.4B | 1.38B |
| Total Equity | 796.21M | 834.22M | 854.66M | 881.83M | 932.9M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.78B | 1.75B | 1.77B | 2.3B | 2.3B |
| Total Liabilities | 1.06B | 1.04B | 980.58M | 1.55B | 1.47B |
| Total Equity | 710.47M | 709.04M | 785.44M | 745.55M | 834.22M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 68.95M | 125.35M | 29.12M | 72.43M | 123.63M |
| Investing | -15.18M | -20.03M | -2.04M | -5.63M | -9.04M |
| Financing | -51.67M | -110.43M | -17.01M | -61.1M | -99.93M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 95.13M | 64.53M | 111.77M | 33.37M | 125.35M |
| Investing | -387.66M | -13.64M | -14.87M | -249.53M | -20.03M |
| Financing | 300.88M | -52.06M | -101.55M | 225M | -110.43M |
| Market Cap | 3.12B |
| Price to Earnings Ratio | 48.38 |
| Price to Sales Ratio | 2.51 |
| Price to Cash Ratio | 128.35 |
| Price to Book Ratio | 3.74 |
| Dividend Yield | - |
| Shares Outstanding | 30.75M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 6.01 (5.67%) |
| Company Name | CONMED Corporation |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.conmed.com |
| Industry | electromedical apparatus (3845) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
